ABSTRACT
OBJECTIVE: This study aims to evaluate the effectiveness of local hyaluronic acid (HA) administration to surgically remove impacted third molar sockets and measure pain, swelling, and trismus. MATERIALS AND METHODS: The study included a total of 25 healthy patients aged 18-29 years with asymptomatic bilaterally impacted lower third molars. All cases have been performed under local anesthesia. In the study group, 0.8% HA (Gengigel®) was applied in the postextraction sockets of the right third molars and in the control group nothing was applied to the extraction sockets of the left third molars. Postoperative pain, trismus, and swelling were evaluated on the 1st, 3rd, and 7th postoperative days. RESULTS: No difference was determined between groups in facial swelling and maximum mouth opening. However, the amount of pain significantly reduced in HA groups according to visual analog scale (P = 0.001). CONCLUSION: The results of this study showed that HA can produce an analgesic action in postextraction sockets after surgical removal of impacted teeth and therefore it has a clinical benefit to reduce usage of nonsteroidal anti-inflammatory drugs after dentoalveolar surgery.
Subject(s)
Hyaluronic Acid/pharmacology , Molar, Third/surgery , Pain, Postoperative/drug therapy , Tooth Extraction , Tooth, Impacted/surgery , Adult , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Case-Control Studies , Edema/epidemiology , Female , Humans , Hyaluronic Acid/administration & dosage , Male , Naproxen/therapeutic use , Pain Measurement , Pilot Projects , Prospective Studies , Tooth, Impacted/epidemiology , Treatment Outcome , Trismus/epidemiology , Visual Analog ScaleABSTRACT
The objective of this study was to analyze changes in expression pattern of Slit1 and Robo2, and to clarify the relationship between these changes and functional recovery of the axotomized inferior alveolar nerve (IAN) without repair using a rat IAN axotomy model. Slit1 and Robo2 were weakly expressed in samples taken from trigeminal ganglion (TG) and IAN of sham surgery rats. In axotomized rats, expression levels increased significantly from day 2 to day 28 post-axotomy, with peaks on days 14 (Slit1) and 7 (Robo2) after axotomy (relative to sham: Slit1 in TG P<0.0005, Slit1 in IAN P = 0.003, Robo2 in TG P<0.0005, and Robo2 in IAN P<0.0005). Over-expressed Slit1 and Robo2 in both the TG and IANs of axotomized rats did not return to sham levels during the 28-day observation period of this study. The regeneration and functional recovery of axotomized IAN was evaluated by jaw opening reflex (JOR) recorded before and after axotomy. JOR occurrence (0% on day 7, 35% on day 14, and 85% on day 28) increased gradually, and the relative threshold of electrical stimulation eliciting JOR decreased gradually (1000.0 ± 0.0% on day 7, 854.3 ± 132.5% on day 14, and 302.6 ± 92.3% on day 28). On day 28 after axotomy, JOR occurrence and the relative JOR threshold had almost returned to those of sham rats. These findings suggest that Slit1 and Robo2 are involved in the regeneration and functional recovery of the axotomized IAN.
Subject(s)
Mandibular Nerve/metabolism , Mandibular Nerve/surgery , Nerve Regeneration/physiology , Nerve Tissue Proteins/metabolism , Receptors, Immunologic/metabolism , Trigeminal Ganglion/metabolism , Animals , Axotomy , Blotting, Western , Electrophoresis , Electrophysiology , Pilot Projects , Rats , Rats, Sprague-Dawley , Time FactorsABSTRACT
Benzaldehyde (BA) occurs naturally in a number of plants, including cherry, fig and peach fruit and carnation flowers at therapeutic doses. In addition, it is used in cosmetics, personal care products and food as a preservative. In this study, we aimed to determine the cytotoxic and apoptotic effects of different concentrations of BA on cultured human lymphocytes using lactate dehydrogenase assay, cell proliferation (water-soluble tetrazolium salts-1) assay and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) test (apoptotic test) as a group of cytotoxicity tests at 6th and 24th h on human lymphocyte cell culture. The cytotoxicity increased when cells were treated with 10, 25 and 50 µg/mL concentrations of BA (p < 0.05). Moreover, treatment of the cells with the same concentrations significantly decreased the cell number at the 6th and 24th hours (p < 0.05). TUNEL assay results also show that the concentration of BA at 10, 25 and 50 µg/mL caused DNA damage significantly (p < 0.05). According to our results, the toxic and genotoxic effects of BA have to be further evaluated before using in cosmetic and food products.
Subject(s)
Benzaldehydes/toxicity , Cytotoxins/toxicity , Lymphocytes/drug effects , Apoptosis/drug effects , Biological Assay , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , DNA Damage , Humans , In Situ Nick-End Labeling , L-Lactate Dehydrogenase/metabolism , Lymphocytes/metabolism , Tetrazolium Salts/metabolismABSTRACT
OBJECTIVE: The aim of conducting this study was to evaluate the effect of zoledronic acid (ZA) on the new bone formation (NBF) after the insertion of a titanium dental implant, which is very popular treatment in dentistry. STUDY DESIGN: Twelve New Zealand white rabbits were used in this study. The rabbits were divided in two groups. ZA was systemically administered to the study group. Titanium implants were placed to the left and right tibias of the rabbits. RESULTS: The data from the ZA group revealed a statistically significant increase in the bone mineral content and the bone mineral density. A non-decalcified histomorphometric examination conducted on the study group revealed a significant increase of NBF and bone-implant contact (BIC) at 2 and 4 weeks. CONCLUSION: A single dose of systemic ZA administration increases the rate of NBF and augments the quality of the bone.
Subject(s)
Bone Density Conservation Agents/pharmacology , Dental Implants , Diphosphonates/pharmacology , Imidazoles/pharmacology , Osseointegration/drug effects , Absorptiometry, Photon/methods , Animals , Bone Density/drug effects , Bone Density Conservation Agents/administration & dosage , Densitometry/methods , Dental Materials/chemistry , Diphosphonates/administration & dosage , Image Processing, Computer-Assisted/methods , Imidazoles/administration & dosage , Infusions, Intravenous , Osteogenesis/drug effects , Rabbits , Random Allocation , Tibia/drug effects , Tibia/pathology , Tibia/surgery , Time Factors , Titanium/chemistry , Zoledronic AcidABSTRACT
The aim of this study is to investigate the effects of the Ankaferd Blood Stopper® (ABS), on cell viability, cytotoxicity, and erythrocyte numbers in in vitro cultured human blood cells. We studied the cytotoxic effects of the ABS using lactate dehydrogenase (LDH) assay, cell proliferation (WST-1) assay and hemolytic assay. The cytotoxicity increased when cells were treated with ABS dilutions of 5%, 12.5%, 25%, and 50% (p < 0.05). Moreover, treatment of the cells with the same concentrations significantly elevated the cell number at 24 and 48 h (p < 0.05). ABS causes a significant increase (p < 0.05) in the hemolytic activity on human erythrocytes and hemolytic activity increases with increase in ABS concentrations. The red blood cell aggregation and cell membrane disruption during the coagulation process lead to induction of hemolytic activity and increase of LDH level in cell culture medium. In addition, ABS has proliferative effects on human leukocytes. Based on these results, ABS can be used as an alternative blood stopping agent safely.
